Dr. Bharat Tewarie is a C-level executive with extensive experience in the BioPharma, Medical Devices and Digital Health industry.
After his training as medical doctor (MD) with an MBA, he has held roles with increasing commercial responsibilities in Europe and USA. These were at multinational BioPharma companies such as Boehringer Ingelheim, Roche, Serono International, EMD Serono, Merck Serono, UCB and other emerging biotech & digital health companies.
From 2015-2020, Bharat worked as the Executive Vice President & Chief Marketing Officer and member of the Executive Committee of UCB. In January 2020, he founded Boston BioPharma Consultants advising executives of BioPharma and medical device companies about commercial topics. In January 2021 he became the CEO and Chairman of an early-stage antiviral development company ViroCarb Inc, and in June 2021 he joined Aveta Biomics as an independent Board director. Since September 2023, Bharat is the CEO of Prana Biosciences and a member of the Board of Directors.
He is also mentoring CEOs of Biotech and Digital Tech companies in the Ednless Frontiers Lab program at New York University’s Stern School of Business.